Back

Results of a heart team assessment of aortic stenosis candidates for percutaneous valve replacement in an upper-middle-income country

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: New insights into aortic stenosis Valvular Heart Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Marcelo Sergio Trivi

Instituto Cardiovascular De Buenos Aires, Buenos Aires (Argentina)

6 More presentations in this session

Presentation thumbnail
Multi-dimensional evaluation in patients with aortic stenosis who are candidates for cardiac surgery
Doctor F. Bonanni (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
The prognostic value of left atrial strain in patients with low-flow, low-gradient aortic stenosis
Doctor C. Ozturk (Bonn, DE)
Abstract Slides Video
Presentation thumbnail
Real world application of left ventricular outflow tract diameter prediction and clinical implications
Doctor C. Matese (Ferrara, IT)
Abstract Slides Video
Presentation thumbnail
Quantification of aortic valve fibrosis and calcification by computed tomography angiography: a prospective head-to-head comparison with histology
Doctor K. Grodecki (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
The effect of aortic valve replacement on 4D flow-measured flow displacement in patients with bicuspid and tri-leaflet aortic valves with severe aortic stenosis
Doctor C. Richards (Leicester, GB)
Abstract Slides Video

Access the full session

Session thumbnail
New insights into aortic stenosis

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
TAVI in very elderly patients: long-term outcomes in a real-world cohort
thumbnail
Congress Presentation
Comparison of outcomes between TAVI and SAVR in patients with bicuspid aortic valve stenosis
thumbnail
Congress Presentation
Outcomes of transcatheter aortic valve implantation in young low-risk patients: a comprehensive meta-analysis of efficacy and safety

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources